| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Sep―11 |
An increasing tendency of precocious puberty among Korean children from the perspective of COVID-19 pandemic effect |
Choi KH, Park SC |
| 2 |
[GO] |
2023―Sep―11 |
Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries |
Birkebaek NH, Kamrath C, Grimsmann JM, Aakesson K, Cherubini V, Dovc K, et al. (+20) de Beaufort C, Alonso GT, Gregory JW, White M, Skrivarhaug T, Sumnik Z, Jefferies C, Hortenhuber T, Haynes A, De Bock M, Svensson J, Warner JT, Gani O, Gesuita R, Schiaffini R, Hanas R, Rewers A, Eckert AJ, Holl RW, Cinek O |
| 3 |
[GO] |
2023―Sep―11 |
The bad rainbow of COVID-19 time: effects on glucose metabolism in children and adolescents with obesity and overweight |
Giannini C, Polidori N, Chiarelli F, Mohn A |
| 4 |
[GO] |
2023―Sep―11 |
The Coronavirus Disease 2019 pandemic is associated with a substantial rise in frequency and severity of presentation of youth-onset type 2 diabetes |
Magge SN, Wolf RM, Pyle L, Brown EA, Benavides VC, Bianco ME, et al. (+21) Chao LC, Cymbaluk A, Balikcioglu PG, Halpin K, Hsia DS, Huerta-Saenz L, Kim JJ, Kumar S, Levitt--Katz LE, Marks BE, Neyman A, O'Sullivan KL, Pillai SS, Shah AS, Shoemaker AH, Siddiqui JAW, Srinivasan S, Thomas IH, Tryggestad JB, Yousif MF, Kelsey MM |
| 5 |
[GO] |
2022―Sep―16 |
Telemedicine and COVID-19 pandemic: the perfect storm to mark a change in diabetes care results from a world-wide cross-sectional web-based survey |
Giani E, Dovc K, TJ Dos Santos, Chobot A, Braune K, Cardona-Hernandez R, et al. (+2) C De Beaufort, Scaramuzza A |
| 6 |
[GO] |
2021―Sep―22 |
Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany? |
Tittel SR, Rosenbauer J, Kamrath C, Ziegler J, Reschke F, Hammersen J, et al. (+5) Monkemoller K, Pappa A, Kapellen T, Holl RW, DPV Initiative |
| 7 |
[GO] |
2021―Sep―22 |
COVID-19 and metabolic diseases: a heightened awareness of health inequities and a renewed focus for research priorities |
Cefalu WT, Rodgers GP |
| 8 |
[GO] |
2021―Sep―22 |
Impact of lockdown in COVID-19 on glycemic control in patients with type 1 diabetes mellitus |
Verma A, Rajput R, Verma S, Balania VKB, Jangra B |
| 9 |
[GO] |
2021―Sep―22 |
Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia |
d'Annunzio G, Maffeis C, Cherubini V, Rabbone I, Scaramuzza A, Schiaffini R, et al. (+3) Minuto N, Piccolo G, Maghnie M |
| 10 |
[GO] |
2021―Sep―22 |
Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany |
Clemens Kamrath, Kirsten Monkemoller, Torben Biester, Tilman R Rohrer, Katharina Warncke, Johanna Hammersen, Reinhard W Holl |
| 11 |
[GO] |
2021―Sep―22 |
Association of vitamin D levels, race/ethnicity, and clinical characteristics with COVID-19 test results |
David O Meltzer, Thomas J Best, Hui Zhang, Tamara Vokes, Vineet M Arora, Julian Solway |
| 12 |
[GO] |
2021―Sep―22 |
Characteristics of hospitalized children with SARS-CoV-2 in the New York city metropolitan area |
Verma S, Lumba R, Dapul HM, Gold-von Simson G, Phoon CK, Lighter JL, et al. (+12) Farkas JS, Vinci A, Noor A, Raabe VN, Rhee D, Rigaud M, Mally PV, Randis TM, Dreyer B, Ratner AJ, Manno CS, Chopra A |
| 13 |
[GO] |
2021―Sep―21 |
COVID-19 and the pituitary |
Frara S, Allora A, Castellino L, di Filippo L, Loli P, Giustina A |
| 14 |
[GO] |
2020―Okt―29 |
Obesity could shift severe COVID-19 disease to younger ages |
Kass DA, Duggal P, Cingolani O |
| 15 |
[GO] |
2020―Okt―29 |
Outcomes in patients with hyperglycemia affected by covid-19: Can we do more on glycemic control? |
Sardu C, D’Onofrio N, et al. Balestrieri ML, |
|
